Abstract
Invited for this month's cover is Prof. Francesco Trotta's group from the University of Torino, Italy. The cover picture shows the chemical structure of a glutathione-responsive β-cyclodextrin nanosponge, bearing disulfide bridges and loaded with anticancer doxorubicin (red and white pills). Glutathione thiol groups are able to reduce the nanosponge disulfide moieties. The cleavage of the disulfide bridges allows a targeted release of anticancer drugs into glutathione-rich chemoresistant tumor cells. Read the full text of the article at 10.1002/cplu.201500531.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
